SCHEMBL4564935

SCHEMBL4564935

COC(=O)c1c(C)c(C#N)c(N)n1-c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.70
HPGD P15428 5/20 0.50
HSD17B10 Q99714 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALOX15 P16050 2/20 0.50
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
KDM4E B2RXH2 7/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.45
RXFP1 Q9HBX9 2/20 0.44
TP53 P04637 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 2/20 0.42
USP2 O75604 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
CASP7 P55210 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6673711 0.83 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4521261 0.82 ALDH1A1 (0.52) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4896130 0.81 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4532187 0.80 ALDH1A1 (0.49) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4532269 0.76 ALDH1A1 (0.51) ALDH1A1HPGDSMN1; SMN2CYP1A2CYP2C9
SCHEMBL11340384 0.76 ALDH1A1 (0.57) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4520363 0.74 ALDH1A1 (0.53) ALDH1A1HPGDSMN1; SMN2KDM4ELMNA
SCHEMBL4523252 0.74 HTT (0.52) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4518839 0.71 SMN1; SMN2 (0.47) ALDH1A1HPGDHSD17B10SMN1; SMN2ALOX15
SCHEMBL4531554 0.70 ALDH1A1 (0.48) ALDH1A1HPGDSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498334-B2 Pyrrolopyrimidines as phosphodiesterase VII inhibitors MERCK PATENT GMBH (DE) 2009-03-03 US disclosed
US-20050059686-A1 Pyrrolopyrimidines as phosphodiesterase vII inhibitors MERCK PATENT GESELLSCHAFT (DE) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059686-A1 Pyrrolopyrimidines as phosphodiesterase vII inhibitors PDE5A, PDE3B, PDE4A ALDH1A1 1713/4885HPGD 991/4885HSD17B10 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.